Reproducible, high-precision wire myography.

Study vascular function across species using a trusted design—updated for today's lab.

#vascularresearch #myography #biomedicaltools #preclinical

Expert-guided AI conversational tools can bolster preventive healthcare potential to jumpstart the Canadian economy, this transformative technology also offers ground-breaking opportunities in healthcare.

Expert-guided AI conversational tools can bolster preventive healthcare

#Vascularhealth #vascularresearch #AI #health #healthprevention #AIhealth

quoimedia.com/expert-guide...

🎉Vascular Pharmacology Young Researcher Award 2025! Support emerging scientists—apply or nominate today! #VascularResearch #YoungScientists
More detials: www.sciencedirect.com/journal/vasc...

👏Big congrats to Dr. Sujin Lee for winning the Outstanding Research Fellow Mentor Award AND the SVS Foundation Award for her research on the FNDC1 protein in vascular calcification! She’s been a Malhotra Lab fellow since 2021, supported by an NIH F32 grant. Amazing work!
#VascularResearch #STEM #MGH

Dr. Ross Clark, MD, MBA, FSVS from #UNMSurgery will present at #SANDIA2025 on carotid plaque microplastics and their link to clinical symptoms, with findings on stem cell and macrophage immune signaling.
#Microplastics #VascularResearch #SurgicalResearch

Interplay of actin nematodynamics and anisotropic tension controls endothelial mechanics - Nature Physics Blood flow through a vessel deforms vessel walls. Cells lining these walls sense the changes in pressure as blood flows and reorient their actin fibres in the direction of largest tension.

How do blood vessels adapt to pressure? 🩸
A new collaborative study from the Salbreux lab shows how changes in endothelial cells help vessels stretch and stay strong — thanks to actin fibers and a smart mechanical model.
📄 www.nature.com/articles/s41...
#Biomechanics #VascularResearch

📍 Welcome North Bristol NHS Trust to EVeR!

Let’s keep the momentum going — each patient entered brings us closer to better vascular care for all.

💻 Is your site up and running? Now’s the time to log in and start contributing!
esvs.org/ever-venous-...

#EVeR #VascularResearch #NorthBristolNHS #ESVS

🚨 The April edition of EJVES Vascular Forum – Volume 63 is live! 🚨

📖 Read the full April edition here: www.ejvesreports.com/inpress

📝 Submissions are open! Be part of the next issue and share your work with the vascular community.

#ejvesforum #VascularSurgery #VascularResearch #OpenAccess

👋 Hello, BlueSky Community!

We are thrilled to launch our official BlueSky page for the CLARITY Trial!
Follow us here for the latest updates and an inside look at the progress and milestones of our trial. We’re looking forward to connecting with each of you!
#VascularResearch #PAD #ClarityPADTrial

5/6 📌 Conclusion: The downsizing post-closure technique demonstrates potential as an effective method for access hemostasis in emergency EVAR. Calls for validation via larger studies to confirm the findings

🔗 Full study: doi.org/doi:10.1007...

#VascularResearch #MedTwitter

Safety and efficacy of chocolate balloon in the treatment of infrapopliteal artery disease - CVIR Endovascular Objective To evaluate the safety and efficacy of chocolate balloons in patients with chronic limb-threatening ischemia (CLTI) and infrapopliteal artery disease, and compare them with conventional balloons. Methods This single-center retrospective study included 167 patients with CLTI and infrapopliteal who underwent endovascular intervention with or without chocolate balloons from September 1, 2019 to June 30, 2023. The primary endpoint was amputation-free survival (AFS). Secondary endpoints included major amputation, the absence of clinically driven target lesion revascularization (CD-TLR), the incidence of flow-limiting dissection, below-the-knee (BTK) stent implantation, change in Rutherford clinical grade, procedural success, and major adverse cardiovascular events (MACEs). Patients were followed at 30 days, 6 months, and 12 months to assess symptom improvement, vascular patency as determined by dual-function ultrasound or angiography, and survival. Results At 12 months, AFS was no

5/6 📌 Conclusion: Chocolate balloons show potential for reducing flow-limiting dissection and BTK stent use in CLTI. However, more research is needed for conclusive AFS benefits.

Read more: doi.org/doi:10.1186...

#VascularResearch #MedicalInnovation #InterventionalRadiology